# Safe Sips Act Proposes a Federal Marker for Intoxicating Drinks > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/safe-sips-act-cannabis-beverage-labels/ > **Published:** 2026-08-03T23:26:36-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:47:57-04:00 > **Clinical Summary:** The Safe Sips Act would create a federal marker for THC beverages and other intoxicating drinks. CED explains the proposal, limits, and safety context. --- CED Clinical Relevance #84 Fresh federal consumer-safety proposal H.R. 9913 proposes a common visual and accessible marker for intoxicating beverages. The bill is newly introduced, clinically relevant to accidental exposure and product recognition, and has no matching CED title or source. Clinical Insight | CED Clinic The Safe Sips Act addresses a practical safety problem: an intoxicating beverage may resemble an ordinary seltzer, soda, or energy drink. A common marker could make the distinction easier to notice, including at the point where a container is opened. The proposal does not establish that one color will prevent accidental ingestion, and it does not replace clear ingredient, cannabinoid, dose, serving-size, or impairment warnings. For patients and families, the immediate safeguards remain product-specific counseling, original packaging, secure storage, and avoiding any unlabeled or transferred beverage. Federal PolicyTHC BeveragesLabelingAccidental Exposure[Consumer Safety](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) Audience Patients, families, clinicians, caregivers, policymakers, and cautious consumers. Primary Topic H.R. 9913, the Safe Sips Act, and its proposed common marker for beverages containing THC or other intoxicating substances. Source [Read the official bill record](https://www.congress.gov/bill/119th-congress/house-bill/9913/) A newly introduced House bill would direct federal officials to create one common color and a non-color accessibility marker for drinks containing THC, alcohol, kratom-related compounds, or other intoxicants. It is a proposal, not a current labeling requirement. What This Study Teaches Us The bill would place a shared identifier at a beverage’s dispensing point, such as a cap, lid, cork, or nozzle. It also calls for text, a symbol, a pattern, a tactile feature, or another non-color identifier for people who are blind or colorblind. Why This Matters THC beverages can be packaged in familiar can and bottle formats. Faster recognition may help families and consumers distinguish an intoxicating drink from an ordinary beverage, but only if the system is understandable, consistently applied, and supported by clear product information. Study Snapshot Measure H.R. 9913, Safe Sips Act Sponsor Rep. Nick LaLota of New York Status Introduced and referred to House committees Covered drinks THC, other intoxicating cannabinoids, alcohol, kratom-related compounds, and other intoxicants Proposed visual marker One federally selected color at the dispensing point Accessibility marker A non-color identifier such as text, symbol, pattern, or tactile feature Rulemaking agencies Department of Health and Human Services and Department of the Treasury, through FDA and TTB Timing in proposal Rules within two years, requirements applying to covered drinks after four years Clinical evidence None reported; this is proposed consumer-safety policy Clinical Bottom Line The Safe Sips Act proposes a simple recognition system for intoxicating drinks. It has not become law, and a marker would supplement rather than replace detailed labels, safe storage, dose awareness, and impairment precautions. Opening News Brief Rep. Nick LaLota introduced H.R. 9913, the Safe Sips Act, to create a common identifier for beverages containing THC, other intoxicating cannabinoids, alcohol, kratom-related compounds, or other intoxicants. [Read the official bill record](https://www.congress.gov/bill/119th-congress/house-bill/9913/). The proposal would place the selected color at the dispensing point and require an additional non-color identifier for accessibility. The bill has been referred to the House Energy and Commerce and Ways and Means committees. It is not law. For Patients and Families Do not rely on can shape, flavor, brand styling, or shelf placement to distinguish an intoxicating beverage. Read the entire label and confirm the active intoxicant and amount per serving and container. Keep these drinks in original packaging, store them apart from ordinary beverages, and secure them from children, pets, and anyone who could mistake them for a nonintoxicating drink. For Clinicians Ask specifically about beverages, which can be overlooked when a patient reports [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/). Document the product, intoxicant, milligrams per serving, number of servings consumed, timing, co-use with alcohol or sedating medications, and driving or work plans. Counsel that delayed onset can encourage premature redosing. A future package marker would not make products pharmacologically equivalent. How This Fits the Bigger Picture The proposal tries to create a recognition layer across product categories that are now regulated under different legal frameworks. Its scope extends beyond cannabis beverages to alcohol, kratom-related compounds, and other intoxicants. That breadth may improve consistency, but it also creates a design challenge because the covered drinks have different pharmacology, dose conventions, evidence bases, and risk profiles. What This Does Not Show An introduced bill does not change current packaging requirements. Committee referral does not predict passage, final language, implementation dates, or agency design choices. The proposal includes no outcome data showing fewer accidental ingestions, impaired-driving events, emergency visits, or poison-center calls. Key Clinical Caveats THC beverage effects depend on dose, formulation, prior exposure, food intake, metabolism, co-use, and individual vulnerability. Alcohol, THC, and concentrated kratom-related compounds should not be treated as interchangeable because they share a marker. Pregnancy, adolescence, older age, psychiatric or cardiovascular vulnerability, [liver disease](https://cedclinic.com/cannabis-compounds-may-reverse-fatty-liver-disease/), substance-use risk, and interacting medicines may require additional caution. No intoxicating beverage should be used before driving or hazardous work. Where It Deserves Skepticism The bill sponsor presents the marker as a child-safety and consumer-recognition measure. That is a policy rationale, not evidence that the selected system will work as intended. A marker could create false reassurance if consumers skip the detailed label. Any final design should be tested for recognition, comprehension, color-vision accessibility, literacy, and performance in real retail and home settings. Policy and Advocacy Angle The central policy question is whether a simple cross-category cue can improve recognition without obscuring product-specific information. A strong implementation plan would preserve clear ingredient and dose disclosures, child-resistant packaging where appropriate, age controls, adverse-event surveillance, enforcement, and public education. How Strong Is This Evidence? Strong for describing the introduced bill and its stated requirements because the reporting links to the official congressional record. Limited for predicting passage, agency implementation, consumer comprehension, accidental-ingestion outcomes, or effects on poison-center calls. Where This Paper Deserves Skepticism The proposal is intuitive, but intuitive is not the same as proven. A single marker could be overlooked, misunderstood, imitated, or treated as sufficient when the underlying products differ substantially in intoxicant, concentration, serving size, onset, and duration. What This Paper Does Not Show The bill does not show that Congress will enact it, that agencies will select an effective design, or that the marker will reduce accidental ingestion. It does not establish product safety, dose accuracy, efficacy, purity, or suitability for any patient. How This Fits With the Broader Clinical Conversation Cannabinoid beverages occupy a mixed federal and state landscape, while alcohol and cannabis products can have different labeling, retail, and enforcement systems. A useful national identifier would still need consumer testing, accessibility review, enforcement, and coordination with ingredient lists, cannabinoid content, serving information, age restrictions, and warnings. Dr. Caplan’s Take *A clear visual cue is a reasonable safety concept because people often identify drinks by package shape and front-facing design before reading fine print.* *Clinically, the marker would be only the first question. Patients still need to know what the intoxicant is, how much is present per serving and container, how quickly it may take effect, how long impairment may last, and whether other medications or health conditions increase risk.* What a Careful Reader Should Take Away Treat the bill as an early safety proposal. Until any rule exists, read the full label, keep intoxicating drinks in original packaging, and store them separately from ordinary beverages. Evidence Interpretation Guide Table of Contents - [How to Read the Safe Sips Act Carefully](#How_to_Read_the_Safe_Sips_Act_Carefully)[Four distinctions that matter](#Four_distinctions_that_matter) - [The Same Study Can Mean Different Things Depending on the Question Being Asked](#The_Same_Study_Can_Mean_Different_Things_Depending_on_the_Question_Being_Asked)[Read Beyond the Marker](#Read_Beyond_the_Marker) - [Ask About Beverages](#Ask_About_Beverages) - [Separate and Secure](#Separate_and_Secure) - [Do Not Overstate](#Do_Not_Overstate) - [Test the Design](#Test_the_Design) - [Demand Outcomes](#Demand_Outcomes) - [Preserve Core Warnings](#Preserve_Core_Warnings) - [Build Surveillance In](#Build_Surveillance_In) - [Frequently Asked Questions](#Frequently_Asked_Questions)[Related](#Related) ## How to Read the Safe Sips Act Carefully This is proposed federal legislation, not an active packaging rule. Four distinctions clarify what the bill could and could not do. ### Four distinctions that matter **Proposal versus requirement**No new marker is required unless legislation is enacted and agencies complete rulemaking. **Recognition versus comprehension**Noticing a marker does not ensure that a person understands the intoxicant, dose, onset, or duration. **Shared marker versus shared pharmacology**Alcohol, THC, and kratom-related compounds can have different effects and risks. **Packaging versus prevention**Safe storage, education, age controls, and clear dose information remain necessary. The Policy Question Can agencies design and test a marker that people recognize accurately across products and settings? The Patient Question What intoxicant and dose are in this exact drink, and how might it interact with my health conditions or medications? The Bottom Line Use any future marker as a warning to stop and read, not as a substitute for the full label. CED Perspective Lens ## The Same Study Can Mean Different Things Depending on the Question Being Asked Scientific papers rarely answer a single question. Patients, clinicians, researchers, policymakers, and critics often read the same data differently. The perspectives below explore how this study looks through several evidence-based lenses. Lens Overview The proposal has different implications for patients, clinicians, families, retailers, policymakers, skeptical readers, poison prevention, and public-health evaluation. #### Read Beyond the Marker Identify the intoxicant and dose. Avoid mixing intoxicants or driving. Lens takeaway A symbol cannot replace product details. #### Ask About Beverages Document serving size and total intake. Review interactions and impairment. Lens takeaway Beverages deserve route-specific counseling. #### Separate and Secure Keep original packaging. Store away from ordinary drinks. Lens takeaway Recognition starts with safe storage. #### Do Not Overstate The bill is not law. Keep product-specific disclosures prominent. Lens takeaway A common cue should support clear labeling. #### Test the Design Measure recognition and comprehension. Include disability and literacy testing. Lens takeaway Good intentions need usable implementation. #### Demand Outcomes Track accidental exposures and errors. Watch for false reassurance. Lens takeaway Evaluate whether the marker changes behavior. #### Preserve Core Warnings Dose and serving information remain essential. Child-resistant packaging may still be needed. Lens takeaway One cue is only one safety layer. #### Build Surveillance In Monitor poison-center and emergency data. Compare outcomes before and after implementation. Lens takeaway Policy value should be measurable. Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion](https://cedclinic.com/interact/discussion-forums/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Share this Evidence Watch [X](https://twitter.com/intent/tweet?text=Safe+Sips+Act+Proposes+a+Federal+Marker+for+Intoxicating+Drinks&url=https%3A%2F%2Fcedclinic.com%2Fsafe-sips-act-cannabis-beverage-labels%2F) [LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fsafe-sips-act-cannabis-beverage-labels%2F) [BlueSky](https://bsky.app/intent/compose?text=Safe+Sips+Act+Proposes+a+Federal+Marker+for+Intoxicating+Drinks%20https%3A%2F%2Fcedclinic.com%2Fsafe-sips-act-cannabis-beverage-labels%2F) [Instagram](https://www.instagram.com/drcaplan/) [Substack](https://doctorapprovedcannabis.substack.com/) [RSS](https://cedclinic.com/feed/) Source: [H.R. 9913, Safe Sips Act](https://www.congress.gov/bill/119th-congress/house-bill/9913/) Related Reading at CED Clinic Continue exploring the evidence [Understanding Ohio’s Hemp Beverage Injunction](https://cedclinic.com/ohio-hemp-beverage-ban-injunction-status/) CED context on [hemp-derived THC](https://cedclinic.com/hemp-derived-thc-products-regulation-patient-access/) beverages, legal uncertainty, and patient counseling. [Read the Ohio context](https://cedclinic.com/ohio-hemp-beverage-ban-injunction-status/) [Federal Cannabis Legalization Bill Returns to the Senate](https://cedclinic.com/2026-cannabis-federal-legalization-bill-patients-clinicians/) Why introduced federal cannabis legislation should be separated from current law and clinical evidence. [Review the federal context](https://cedclinic.com/2026-cannabis-federal-legalization-bill-patients-clinicians/) [Texas Hemp Ban Compliance in 2026](https://cedclinic.com/2026-texas-hemp-ban-compliance-patients-clinicians/) Practical guidance on changing hemp rules, product identification, and cautious decision-making. [Read the Texas context](https://cedclinic.com/2026-texas-hemp-ban-compliance-patients-clinicians/) ## Frequently Asked Questions What is the Safe Sips Act? The Safe Sips Act is H.R. 9913, a newly introduced federal bill proposing a common marker for beverages containing THC, alcohol, kratom-related compounds, or other intoxicants. Is the Safe Sips Act currently law? No. It has been introduced and referred to House committees, so it does not currently create a federal labeling requirement. What would appear on covered drinks? The proposal calls for one federally selected color at the dispensing point and an additional non-color identifier for accessibility. Why include a non-color identifier? Text, a symbol, a pattern, a tactile feature, or another cue could help people who are blind or colorblind identify a covered drink. Would the bill apply only to cannabis drinks? No. Its reported scope includes THC and other intoxicating cannabinoids, alcohol, kratom-related compounds, and other intoxicating substances. Would a common marker prove that a drink is safe? No. A marker would identify a category of drink, not verify purity, dose accuracy, efficacy, or suitability for an individual. Would all marked drinks have similar effects? No. The active substance, dose, onset, duration, interactions, and health risks can differ substantially. How should families store intoxicating beverages now? Keep them in original packaging, separate them from ordinary drinks, and secure them from children, pets, and unintended users. What should clinicians ask about THC beverages? Ask about the exact product, THC per serving, total servings consumed, timing, other intoxicants or medicines, adverse effects, and driving plans. What should cautious readers watch next? Watch for committee action, amended text, consumer testing, accessibility review, agency rulemaking details, and evidence about accidental-exposure outcomes. ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).